The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas

Authors:

Abstract
OBJECTIVE To compare effectiveness and tolerability of quinagolide (CV 205–502) and cabergoline (CAB) treatments in 39 patients with prolactinoma. STUDY DESIGN All 39 patients were treated first w...

This publication has 29 references indexed in Scilit: